HDEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Several of the largest positions, such as Roche and Novartis, have shown solid gains this year, helping support the fund’s overall results.
Low Expense Ratio
The fund charges a relatively low fee, which means more of the dividend income and price gains can stay in investors’ pockets over time.
Broad International Diversification
Exposure across many developed markets outside the U.S., including Switzerland, the UK, France, Germany, and Japan, helps spread country-specific risk.
Negative Factors
Mixed Recent Performance
The ETF’s year-to-date return has been slightly negative, showing that it has struggled to gain steady upward momentum so far this year.
Concentration in a Few Countries
A large share of assets is concentrated in Switzerland and the UK, which increases the impact that economic or political issues in those markets can have on the fund.
Heavy Tilt to Financials and Defensives
Significant weight in financial, consumer defensive, and utility stocks may cause the fund to lag when more growth-oriented or technology sectors lead the market.
HDEF vs. SPDR S&P 500 ETF (SPY)
AUM2.31B
RegionDeveloped Markets
Expense Ratio0.09%
Beta0.45
IssuerXtrackers
Inception DateAug 12, 2015
Dividend Yield3.53%
Asset ClassEquity
Index TrackedMSCI EAFE High Dividend Yield
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume121,792
30 Day Avg. Volume210,462
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
35.37Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering112
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HDEF Summary
HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside the U.S. and Canada, such as Europe and Japan. It mainly holds large, established businesses that pay relatively high dividends, including well-known names like Nestlé and Shell. Investors might consider HDEF if they want international diversification and a potential income stream from dividends rather than just growth. A key risk is that the fund is concentrated in foreign and dividend-focused stocks, so its value and income can go up and down with global markets and interest-rate changes.
How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.
What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.
HDEF Top 10 Holdings
HDEF leans heavily on Europe’s dividend stalwarts, with energy and consumer defensive names setting the tone. TotalEnergies and Shell have been doing the heavy lifting lately, rising on the back of firm energy markets and solid cash flows. In contrast, big health care and consumer brands like Roche, Nestlé, and Unilever have been losing steam, acting as a brake on overall returns. Financials such as Allianz and Zurich Insurance are also lagging, so the fund’s income-rich, Europe-focused mix is steady on yield but facing mixed price momentum.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Shell (UK) | 5.54% | $126.81M | £191.74B | 48.20% | 73 Outperform | |
| Novartis AG | 5.48% | $125.59M | CHF222.29B | 41.43% | 80 Outperform | |
| Roche Holding AG | 5.13% | $117.47M | $319.97B | 31.82% | 73 Outperform | |
| TotalEnergies SE | 4.59% | $105.10M | €168.14B | 60.33% | 78 Outperform | |
| Nestlé SA | 4.57% | $104.59M | CHF200.06B | -4.74% | 71 Outperform | |
| Allianz | 4.22% | $96.66M | €142.88B | 15.70% | 67 Neutral | |
| Iberdrola | 3.84% | $88.04M | €135.72B | 37.85% | 67 Neutral | |
| British American Tobacco | 3.20% | $73.31M | £94.23B | 37.91% | 71 Outperform | |
| Unilever | 3.17% | $72.72M | £94.25B | ― | 72 Outperform | |
| Sanofi | 2.59% | $59.29M | €96.54B | -9.05% | 75 Outperform |
HDEF Technical Analysis
Positive
―
Price Trends
32.64
Positive
31.60
Positive
30.32
Positive
Market Momentum
0.17
Negative
63.25
Neutral
94.70
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.20, equal to the 50-day MA of 32.64, and equal to the 200-day MA of 30.32, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 63.25 is Neutral, neither overbought nor oversold. The STOCH value of 94.70 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.
HDEF Peer Comparison
Comparison Results
Performance Comparison
HDEF
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
33.18
7.53
29.36%
IDV
iShares International Select Dividend ETF
―
―
―
DIVI
Franklin LibertyQ International Equity Hedged ETF
―
―
―
FGD
First Trust Dow Jones Global Select Dividend Index Fund
―
―
―
DTH
WisdomTree International High Dividend Fund
―
―
―
EFAS
Global X MSCI SuperDividend EAFE ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents